65,437 trials
Hypertension
Primary: Trough Seated Diastolic Blood Pressure (DBP) Control — 201; 402; 72; 70 patients
Meningococcal Infections · Meningococcal Meningitis
Primary: Number of Participants With At Least One Solicited Injection Site or Systemic Reaction Post-Vaccination 1. — 26; 20; 28; 23 Participants
Schizophrenia
Primary: Change From Baseline in Negative Symptoms of Schizophrenia Measured by the Negative Symptom Assessment (NSA) Scale Total Score — 60.4; 61.3; -9.7; -9.2 Units on a Scale…
Nasopharyngeal Neoplasms · Carcinoma
Primary: Number of Participants With Complete Response (CR) — 1; 0 participants — p=1.0000
Hypertension
Primary: Number of Patients Achieving Blood Pressure (BP) Control, Sitting Diastolic BP Over Systolic BP 90 Over 140 mm Hg and/or Reduction From Baseline in Sitting Systolic BP…
Atrial Fibrillation
Primary: Incidence of Atrial Fibrillation Requiring Treatment — 9; 21 participants — p=0.02
Venous Stasis Ulcers
Primary: Safety and Tolerability of Thymosin Beta 4 (Tβ4) Applied to Patients With Venous Stasis (VS) Ulcers for up to 84 Days — 24; 104 SAEs and AEs
Memory Impairment
Primary: Change From Baseline in Neuropsychological Computerized Test — 3.16; -2.38; 1.88; 4.50 Points on a scale
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in Glycosylated A1c (HbA1c) at Week 26 — -1.12; -0.79 percentage point of total HbA1c — p=<.0001
Coronary Artery Disease
Primary: Percentage of Participants Who Achieved Procedure Success From Post-procedure to Hospital Discharge — 97 Percentage of Participants
Asthma
Primary: Change From Baseline in the Average AM Peak Expiratory Flow (PEF) Over the 7 Days of Week 8. — 361.8; 374.3; 348.4; 6.03 liters/minute — p=0.654
Renal Artery Stenosis
Primary: Prevalence of Renal Artery Stenosis (RAS)
Stage II Hypertension
Primary: Changes in Mean Sitting DBP From Baseline After 4 Weeks of Therapy — -17.0; -14.1 mmHg
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 281.111; 257.194 ng/mL
Rheumatoid Arthritis
Primary: American College of Rheumatology (ACR) 20 at Week 12 — 12 participants